Healing NET Foundation Scientific Advisory Committee
David C. metz, MD
Dr. Metz RECENTLY RETIRED FROM the the University of Pennsylvania, WHERE HE SERVED AS A PROFESSOR OF MEDICINE AND A gastroenterologist. He WAs co-director of Penn’s neuroendocrine tumor center. He served as president of the North american neuroendocrine tumor society (NANETS) from 2016-2018.
ERic Liu, MD, FACS
Healing NET FOunding medical director—Dr. Liu is a surgeon Specialized in neuroendocrine disease. WHILE at Vanderbilt University, Dr. Liu was responsible for establishing the first clinical trial in the United States of the Gallium 68 Pet Scan to diagnose nets. In 2015 he partnered with Dr. Allen Cohn (oncologist) to launch The Neuroendocrine Institute at the Rocky Mountain Cancer Centers in Denver, CO.
Heloisa P. soares, MD, PHD
Dr. Soares is a medical oncologist with a focus in GI cancers and neuroendocrine tumors. She is an assistant professor at the Huntsman Cancer Institute at University of Utah. She serves as the co-physician leader in the GI Clinical Trials Research Group at HCI.
Erik Mittra, MD, PhD
Dr. Mittra is Chief of Nuclear Medicine & Molecular Imaging anD AN Associate Professor of Diagnostic Radiology at Oregon Health & Science University. Targeted Radioisotope Therapies (TRT) are of particular interest, including various applications in oncology, and he is considered a national expert in this area.
Linda Gardner, BSN, RN, VA-BC
LinDA Gardner is an Experienced Administrative Nurse at the university of California Los angeles. She was the Lead nurse for the Peptide Receptor Radionuclide Therapy (PRRT) EAP program. and now leads the fda-approved commercial program. She has helped Healing NET identify how to support nurses in better meeting the needs of net patients.
Daniel Halperin, MD
Dr. Halperin is a medical oncologist and clinical investigator at MD Anderson Cancer Center. He is focused on the development of novel treatments for patients with neuroendocrine tumors (NETs), in addition to providing high-quality clinical care to patients with NETs and other gastrointestinal cancers.
Michael C. Soulen, MD
Dr. SOULEN is Professor of Radiology & Surgery AND Director Interventional Oncology At Abramson Cancer Center, University of Pennsylvania. His research expertise includes image-guided cancer therapy, interventional oncology, AND embolization.
Josh A. Mailman
Josh is an internationally recognized advocate for nET patients AND for integrative oncology, nuclear medicine, and molecular imaging. He is President of the NorCAL Carcinet Community AND has served On Numerous Boards And Committees. JOSH has been a technology entrepreneur for over 20 years.
JOSEPH DILLON, MD
Dr. Dillon is a professor of medicine and Endocrinology at university of iowa, where he directs the neuroendocrine tumor enets center of excellence (coe) and pheo/para alliance coe. his clinical work is focused entirely on the care of people with neuroendocrine tumors (NETS), he is involved with multiple research projects through the NETS spore GRANT.
Jaydira Del Rivero, MD
Dr. Del Rivero is a Physician Scientist in the Developmental Therapeutics Branch at the National Cancer Institute. SHE is board certified in Internal Medicine, Endocrinology, Diabetes and Metabolism and Medical Oncology. HER WORK focuses on the development of novel treatment approaches and targeted therapies for endocrine malignancies such as advanced gastroenteropancreatic neuroendocrine tumors, adrenocortical cancer and pheochromocytoma/paraganglioma.
Emeritus Members of the Scientific Advisory Committee
Hover on each photo to read more.
Joy Ardill, Phd, frcpath
Dr. Ardill has long studied the chemistry of nets. recently SHE was part of the Belfast team Named a Neuroendocrine Tumour Center of Excellence. In addition to her research, she has taught medical students, trained colleagues, and worked with patient support groups. She has spoken at numerous national and international meetings over her 50-year career and is author of more than 100 peer-reviewed publications.
George A. Fisher, Jr., MD, PHD
Dr. Fisher is a Medical oncologist AND GASTROINTESTINAL Specialist at stanForD University. He Provides Care for Patients with gastrointestinal cancers, including neuroendocrine tumors, AND has conducted numerous clinical trials to investigate promising treatment options. Dr. Fisher Participates In cooperative groups under the auspices of the National cancer institute in the hope of establishing new standards of care for GI Cancer.
KJELL ÖBERG, MD, PHD
Dr. Öberg IS AN EMERITUS Professor of Endocrine Oncology ON the Medical Faculty of Uppsala University. He was the former head of the Department of Endocrine Oncology, University Hospital, and he is a specialist in endocrinology and internal medicine. He has OVER 30 years experience in the field of neuroendocrine tumors.
